Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Asia
The Indian Patent Office has approved pharmaceutical company Pfizer’s application to patent its Prevenar 13 (pneumococcal 7-valent conjugate) drug, despite claims by Médecins Sans Frontières that it is too obvious.   24 August 2017
Americas
The biggest challenges in the life sciences concern second medical use patents and incentives for innovation, according to Lydia McNally, vice president, head of patents, oncology at Novartis.   23 August 2017
Americas
German therapeutics developer Ethris has agreed a €25 million ($29 million) research deal with AstraZeneca focused on developing therapies for respiratory diseases.   23 August 2017
Americas
Gene-editing company CRISPR Therapeutics has partnered with the cancer centre at Massachusetts General Hospital to develop T cell therapies for treating the disease.   23 August 2017
Americas
Abbott Laboratories has fended off patent infringement claims filed by Enzo Biochem after convincing a US court that the patents did not describe the invention in a sufficient way.   22 August 2017
Asia-Pacific
Samsung’s biopharmaceutical arm Samsung Bioepis has agreed a deal with Takeda to tackle “unmet disease areas”, marking the South Korean company’s move into the novel drugs market.   22 August 2017
Americas
Johnson & Johnson has been handed another victory in its fight against counterfeits after being granted an injunction preventing several companies from selling “potentially deadly” versions of a blood glucose strip it produces.   21 August 2017
Americas
Procter & Gamble has failed to sue an alleged patent infringer after falling foul of the US Supreme Court’s clarification on appropriate venues for litigation.   21 August 2017
Americas
Mylan has finalised a $465 million payment to the US government to settle a lawsuit about the classification of EpiPen Auto-Injector (epinephrine) under the Medicaid Drug Rebate Program.   18 August 2017
Americas
Two US House Representatives have begun an investigation into the pricing of drugs used to treat multiple sclerosis.   18 August 2017